WHO Laboratory Biosafety Manual

WHO Laboratory Biosafety Manual
Name	WHO Laboratory Biosafety Manual
Publisher	World Health Organization
Language	English
Subject	Biosafety, biosecurity, laboratory practice
Release date	2004 (4th ed.), 2020 (4th ed. annexes and updates)

WHO Laboratory Biosafety Manual

The WHO Laboratory Biosafety Manual is a technical guidance document published by the World Health Organization to standardize laboratory biosafety and biosecurity practices across clinical, diagnostic, and research settings. It is referenced by public health agencies such as the Centers for Disease Control and Prevention, the European Centre for Disease Prevention and Control, and national ministries including the Ministry of Health (United Kingdom), and informs implementation in institutions like the Pasteur Institute, the Robert Koch Institute, and the National Institutes of Health (United States). The Manual influences international frameworks such as the International Health Regulations (2005), the Nagoya Protocol, and programs run by the Bill & Melinda Gates Foundation.

Overview

The Manual consolidates biosafety guidance drawn from organizations including the World Organisation for Animal Health, the Food and Agriculture Organization of the United Nations, and the United Nations Office for Disaster Risk Reduction to address handling of pathogens ranging from agents studied at the Centers for Disease Control and Prevention to emerging threats encountered in outbreaks like Ebola virus epidemic in West Africa and SARS coronavirus outbreak of 2003. It frames risk assessment approaches used by laboratories such as those at the Wellcome Sanger Institute and the Broad Institute and intersects with standards promulgated by bodies like the International Organization for Standardization and the European Committee for Standardization. The Manual targets audiences including laboratory directors at institutions such as the Johns Hopkins Bloomberg School of Public Health and biosafety officers trained in programs like those at Fort Detrick.

Editions and Revisions

Initial editions built on earlier WHO technical series and were revised in consultation with stakeholders including experts from the Centers for Disease Control and Prevention, the Robert Koch Institute, and national public health institutes such as the Public Health Agency of Canada. Major revisions accompanied public health events such as the H1N1 pandemic (2009) and the COVID-19 pandemic, prompting updates coordinated with agencies like the European Centre for Disease Prevention and Control and research centers such as the National Institute for Biological Standards and Control. The fourth edition consolidated lessons from laboratories involved in outbreaks like Middle East respiratory syndrome coronavirus investigations and incorporated technical input from the International Federation of Biosafety Associations and universities such as Oxford University and Harvard University.

Key Principles and Risk Management

The Manual emphasizes systematic risk assessment and management used by biosafety committees at institutions including the University of Cambridge and the University of California, San Francisco, drawing on methodologies linked to incident responses in events like the 2014–2016 Ebola epidemic and laboratory investigations at the Walter Reed Army Institute of Research. It prescribes engineering controls exemplified in facilities operated by the Max Planck Society and administrative controls used by the National Health Service (England), and aligns with pathogen classification schemes referenced by the Centers for Disease Control and Prevention and the European Union's lists for biological agents. Guidance for personal protective equipment echoes procurement standards used by organizations such as Médecins Sans Frontières and procurement frameworks of the World Bank.

Laboratory Containment Levels and Practices

The Manual defines containment levels analogous to biosafety levels used in laboratories from the Rockefeller University to the Salk Institute, detailing practices for primary containment (e.g., biological safety cabinets used in the Pasteur Institute) and facility design elements found in high-containment centers like those at Fort Detrick and the National Microbiology Laboratory (Canada). It discusses decontamination protocols tested in responses to incidents at research sites such as the University of Iowa and waste management approaches coordinated with agencies like the Environmental Protection Agency (United States). The Manual also addresses transport regulations intersecting with the International Air Transport Association and legal frameworks like the Convention on Biological Diversity.

Implementation and Training

Implementation guidance targets capacity building programs run by organizations including the World Health Organization, the United States Agency for International Development, and the Global Fund and advises training regimens similar to courses at the London School of Hygiene & Tropical Medicine and the George Washington University Milken Institute School of Public Health. It recommends competencies for biosafety officers comparable to curricula developed by the International Federation of Biosafety Associations and collaborative exercises used in simulation studies at the Johns Hopkins Center for Health Security and the European BioSafety Association.

Global Impact and Adoption

The Manual has been adopted, adapted, or referenced by national guidelines in countries with institutions such as the Chinese Center for Disease Control and Prevention, the Indian Council of Medical Research, and the Brazilian Ministry of Health, and it informs laboratory accreditation schemes run by bodies like the International Organization for Standardization and the College of American Pathologists. Its influence is evident in outbreak laboratory networks mobilized during crises including the 2014 West Africa Ebola outbreak and the COVID-19 pandemic, and in capacity-strengthening initiatives funded by donors such as the Gavi, the Vaccine Alliance.

Criticisms and Updates

Critiques from commentators at institutions such as Harvard University, the London School of Hygiene & Tropical Medicine, and civil society groups including Amnesty International have focused on gaps in operationalization, equity of access to resources, and clarity for low-resource settings highlighted during events like the 2014–2016 Ebola epidemic and the COVID-19 pandemic. WHO-led revisions have sought to address these concerns through consultations with stakeholders including the Global Health Security Agenda and technical input from research centers such as the Wellcome Trust and the Rockefeller Foundation, while debates continue in forums like the World Health Assembly and multi-stakeholder platforms including the Global Preparedness Monitoring Board.

Category:World Health Organization publications